Home › Traumatic Brain Injury › NCT04296604
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
RecruitingHealthy volunteers welcome
Who can join
Ages 18 to 65 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria 1. Male and female outpatients 18-65 years of age 2. A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. Exclusion Criteria 1. Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy. 2. Active substance dependence (except for tobacco and cannabis). 3. Pregnant or nursing females. 4. Inability to participate in testing procedures. 5. Additional exclusion criteria for healthy controls: 1. Diagnosis of psychiatric of neurological disorder 2. Ongoing treatment with any psychotropic medications.
About the study
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
What is being tested
- Transcranial Direct Current Stimulation (device)
Sponsor: Massachusetts General Hospital · Participants: 600 · Started: 2014-09
Contact the study team
- Joan Camprodon, MD, PhD, MPH · Phone: 6177265348
- Patricia Cirillo, MD, PhD · Phone: 6177243217
Official record on ClinicalTrials.gov — NCT04296604
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
Conditions
- Traumatic Brain Injury
- Major Depressive Disorder
- Bipolar Disorder
- Schizophrenia
- Attention Deficit Hyperactivity Disorder
- Borderline Personality Disorder
- Drug Use and Addiction
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.